Ad Alert

Pathogen Defense, Other APS BioGroup Supplements

Products' labeling comes under attack.

Ad Alert

Pathogen Defense, Other APS BioGroup Supplements

To borrow a line from Jeff Green of HBO’s “Curb Your Enthusiasm,” some APS BioGroup supplement labels are “just a big bowl of wrong.”

But before we get to the main course of a recent FDA warning letter to the company — a helping of Only FDA-approved drugs can be marketed as having the ability to diagnose, cure, treat, prevent or mitigate a disease., one of which is the very name of a supplement, Pathogen Defense — let’s dig into some apps.

According to the agency, certain APS BioGroup supplement labels are misbranded in that they, among other things:

  • Give an incorrect serving size (Pathogen Defense)
  • Fail to list all the common names of each ingredient (Pathogen Defense, Liver Defend, and others)
  • Claim to be “rich” in an ingredient, proline, for which there is no such measure (DPS Throat Spray)
  • Display the Nutrition Facts Panel in an incorrect format (Children’s DiaResQ)

The illegal health claims cited on the label of Pathogen Defense, in addition to the name of the product, includes the claim that the supplement addresses “the overgrowth and infectious potential of various pathogens…”

Remember, readers, marketing supplements as having the ability to treat, cure, alleviate the symptoms of, or prevent developing diseases and disorders is simply not permitted by law. If a supplement really could do all that, then it would be a drug subject to rigorous study and testing to gain FDA approval.

Find more of our coverage on supplements here.


Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.


You Might Be Interested In

Enlifta

Ad Alert

Enlifta

FDA targets supplement sellers on Amazon making unapproved disease-treatment claims.